-
GENERATIVE AI SECURES SYNTHETIC DATASETS OF NSCLC TRIAL COHORTS FOR RWD ANALYSIS: A PRIVACY-PRESERVING CASE STUDY
Mar 18, 2026, 21:38 PM -
INFLAMMATORY BIOMARKERS AND RHEUMATOID ARTHRITIS: EVIDENCE FROM A US POPULATION-BASED NHANES STUDY
Mar 18, 2026, 21:38 PM -
COMBINING PLASMA COLLECTION WITH DEMAND DIVERSION TO ACHIEVE IMMUNOGLOBULIN SELF-SUFFICIENCY IN CANADA
Mar 18, 2026, 21:38 PM -
STRUCTURAL HETEROGENEITY IN HEALTH ECONOMIC MODELLING APPROACHES FOR HCV AND HDV DIAGNOSTICS: NEED FOR HARMONIZATION
Mar 18, 2026, 21:38 PM -
DECODING THE PREDICTIVE ROLE OF COMPLETE RESPONSE/REMISSION RATE (CR) FOR OVERALL SURVIVAL (OS) IN RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Mar 18, 2026, 21:38 PM -
ADVANCING CLINICAL DEVELOPMENT AND EVIDENCE GENERATION THROUGH CAUSAL AI: A TARGETED REVIEW OF APPLICATIONS AND IMPLICATIONS FOR REGULATORY-GRADE EVIDENCE
Mar 18, 2026, 21:38 PM -
MODELING RARE EVENTS IN HEALTH INTERVENTION: AN APPLICATION FROM THE DEPARTMENT OF WAR DATASET
Mar 18, 2026, 21:38 PM -
COMPARISON OF HEALTHCARE COSTS BETWEEN RECONSTRUCTION PROCEDURE AND DIRECT AMPUTATION OF LOWER EXTREMITIES AMONG PATIENTS WITH DIABETIC NEUROPATHIC ARTHROPATHY
Mar 18, 2026, 21:38 PM -
CHANGES IN PAIN AND STIFFNESS EXPERIENCED BY PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) IN THE MANEUVER PHASE 3 TRIAL: INSIGHTS FROM EXIT INTERVIEWS
Mar 18, 2026, 21:38 PM -
IMPACT OF GLP-1 RECEPTOR AGONIST (GLP-1 RAS) PERSISTENCE VERSUS DISCONTINUATION ON CARDIOMETABOLIC MEASURES IN POLYCYSTIC OVARY SYNDROME (PCOS) OVER A TWO-YEAR FOLLOW-UP
Mar 18, 2026, 21:38 PM -
ENHANCING REAL-WORLD DATA (RWD) QUALITY: IMPLEMENTATION OF REGULATORY DATA QUALITY FRAMEWORK WITHIN A LARGE US ONCOLOGY ELECTRONIC HEALTH RECORD (EHR)-DERIVED DATABASE
Mar 18, 2026, 21:38 PM -
TRENDS IN UTILIZATION AND OUT-OF-POCKET SPENDING FOR GLP-1 RECEPTOR AGONISTS AMONG U.S. ADULTS WITH TYPE 2 DIABETES, 2018-2023: A MEPS STUDY
Mar 18, 2026, 21:38 PM -
BARRIERS TO RECOVERY AND THE ASSOCIATION BETWEEN SHARED DECISION-MAKING AND RETENTION IN CARE AMONG PERINATAL WOMEN WITH OPIOID USE DISORDER
Mar 18, 2026, 21:38 PM -
IMPACT OF PULMONARY ARTERIAL HYPERTENSION ON HEART-LUNG TRANSPLANTATION OUTCOMES AND COSTS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
REAL-WORLD EVIDENCE (RWE) ON BRUTON TYROSINE KINASE INHIBITORS (BTKIS) IN TREATMENT-NAIVE (TN) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) OR SMALL LYMPHOCYTIC LYMPHOMA (SLL): AN ARTIFICIAL INTELLIGENCE (AI)-ASSISTED LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
DEVELOPMENT OF AN ALCOHOL USE DISORDER IDENTIFICATION MODEL USING ELECTRONIC HEALTH RECORD-DERIVED FEATURES FOR CLINICAL IMPLEMENTATION
Mar 18, 2026, 21:38 PM -
COST-OF-ILLNESS OF PNEUMONIA, BACTEREMIA OR MENINGITIS IN COLOMBIAN ADULTS: A RETROSPECTIVE DATABASE STUDY, 2015 TO 2022
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS AND BUDGET IMPACT OF THE ETONOGESTREL SUBDERMAL IMPLANT INCORPORATING REAL-WORLD UTILIZATION DATA FROM A LARGE BRAZILIAN PRIVATE HEALTH INSURER
Mar 18, 2026, 21:38 PM -
PATIENT-REPORTED OUTCOMES IN UNITED STATES PROMOTIONAL COMMUNICATIONS FOR DRUGS AND BIOLOGICS: A REVIEW OF DRUG PROMOTION UNTITLED LETTERS FROM THE FDA
Mar 18, 2026, 21:38 PM -
COMPARATIVE EFFECTIVENESS ANALYSIS OF FOLFIRINOX AND GEMCITABINE PLUS NAB-PACLITAXEL IN METASTATIC PANCREATIC ADRENOCARCINOMA; USING MARGINAL STRUCTURAL MODEL
Mar 18, 2026, 21:38 PM
